Discussion
Four weekly injections of the antibody therapy daratumumab restored a key enzyme’s activity and triggered a two-year recovery for a woman with hard-to-treat immune-mediated…
Dangerous blood clots that block blood flow are rare in people with von Willebrand disease (VWD), but their risk increases with age and the specific types of clotting problems may vary by biological sex, a new study shows. These clots, known as thrombo-embolic events, can cause severe damage in…
Latest news & perspectives
Discussion
Discussion
A donor stem cell transplant and follow-up treatments helped a teenage girl achieve long-term remission from refractory immune thrombocytopenia (ITP), according to a case…
